Cargando…

Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors

BACKGROUND: Premature discontinuation of aromatase inhibitors (AIs) in breast cancer survivors compromises treatment outcomes. We aimed to evaluate whether patient-reported joint pain predicts premature discontinuation of AIs. METHODS: We conducted a retrospective cohort study of postmenopausal wome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chim, Kannie, Xie, Sharon X, Stricker, Carrie T, Li, Qing S, Gross, Robert, Farrar, John T, DeMichele, Angela, Mao, Jun J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847371/ https://www.ncbi.nlm.nih.gov/pubmed/24004677 http://dx.doi.org/10.1186/1471-2407-13-401

Ejemplares similares

Clinical and genetic risk factors for aromatase inhibitor-associated arthralgia in breast cancer survivors
por: Romero, Sally A.D., et al.
Publicado: (2019)

Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors
por: Mao, Jun J, et al.
Publicado: (2011)

Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment
por: Wang, Tao, et al.
Publicado: (2022)

Adaptation of an Evidence-Based Arthritis Program for Breast Cancer Survivors on Aromatase Inhibitor Therapy Who Experience Joint Pain
por: Nyrop, Kirsten A., et al.
Publicado: (2015)

Physical activity and telomere length in early stage breast cancer survivors
por: Garland, Sheila N, et al.
Publicado: (2014)

Arthralgia among women taking aromatase inhibitors: is there a shared inflammatory mechanism with co-morbid fatigue and insomnia?
por: Bauml, Joshua, et al.
Publicado: (2015)

Yoga versus massage in the treatment of aromatase inhibitor-associated knee joint pain in breast cancer survivors: a randomized controlled trial
por: Tsai, Chia-Lin, et al.
Publicado: (2021)

327 Nociplastic pain and early discontinuation of aromatase inhibitor therapy in breast cancer patients over age 65
por: Joyce, Elizabeth, et al.
Publicado: (2022)

Aromatase inhibitor use, side effects and discontinuation rates in gynecologic oncology patients
por: Bell, Sarah G., et al.
Publicado: (2020)

Variability of DNA Repair and Oxidative Stress Genes Associated with Worst Pain in Breast Cancer Survivors on Aromatase Inhibitors
por: Wagner, Monica A., et al.
Publicado: (2023)

Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2− metastatic breast cancer
por: Rugo, Hope S., et al.
Publicado: (2022)

Predictors of premature discontinuation of treatment in multiple disease states
por: Nantz, Eric, et al.
Publicado: (2009)

Wide variation in caffeine discontinuation timing in premature infants
por: Ji, Dabin, et al.
Publicado: (2019)

What influences aromatase inhibitor continuation intention among breast cancer survivors?
por: Seo, Young Kyung, et al.
Publicado: (2021)

Endothelial Dysfunction in Breast Cancer Survivors on Aromatase Inhibitors: Changes over Time
por: Shaaban, Adnan, et al.
Publicado: (2023)

Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer
por: Makhlin, Igor, et al.
Publicado: (2022)

Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer
por: Kadakia, Kunal C., et al.
Publicado: (2016)

Provider Decisions and Patient Outcomes After Premature Metformin Discontinuation
por: Bradley, Jessica N., et al.
Publicado: (2017)

Shear wave elastography detects novel imaging biomarkers of aromatase inhibitor–induced joint pain: a pilot study
por: Martinez, Jessica A., et al.
Publicado: (2021)

Real-World Tumor Response of Palbociclib in Combination With an Aromatase Inhibitor as First-Line Therapy in Pre/Perimenopausal Women With Metastatic Breast Cancer
por: DeMichele, Angela, et al.
Publicado: (2023)

Biology of premature ageing in survivors of cancer
por: Cupit-Link, Margaret C, et al.
Publicado: (2017)

Long-Term Effect of Aromatase Inhibition in Aromatase Excess Syndrome
por: Binder, Gerhard, et al.
Publicado: (2021)

Dietary Supplement Use and Interactions with Tamoxifen and Aromatase Inhibitors in Breast Cancer Survivors Enrolled in Lifestyle Interventions
por: Harrigan, Maura, et al.
Publicado: (2021)

Psychological measures of stress and biomarkers of inflammation, aging, and endothelial dysfunction in breast cancer survivors on aromatase inhibitors
por: Blaes, Anne H., et al.
Publicado: (2023)

FRI077 Efficacy Of Anti-obesity Medications Among Breast Cancer Survivors Taking Aromatase Inhibitors
por: Fansa, Sima, et al.
Publicado: (2023)

Premature discontinuation of curative radiation therapy: Insights from head and neck irradiation
por: Lazarev, Stanislav, et al.
Publicado: (2017)

Aromatase inhibitor–associated musculoskeletal pain: An overview of pathophysiology and treatment modalities
por: Grigorian, Nelly, et al.
Publicado: (2022)

Aromatase and 5-alpha reductase gene expression: modulation by pain and morphine treatment in male rats
por: Aloisi, Anna Maria, et al.
Publicado: (2010)

Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor–Related Joint Pain: A Randomized Clinical Trial
por: Hershman, Dawn L., et al.
Publicado: (2022)

Sequencing of aromatase inhibitors
por: Bertelli, G
Publicado: (2005)

Modulation of Aromatase by Phytoestrogens
por: Lephart, Edwin D.
Publicado: (2015)

Aromatase in the Human Brain
por: Azcoitia, Iñigo, et al.
Publicado: (2021)

Aromatase and Dual Aromatase-Steroid Sulfatase Inhibitors from the Letrozole and Vorozole Templates
por: Wood, Paul M, et al.
Publicado: (2011)

Epitope Characterization of an Aromatase Monoclonal Antibody Suitable for the Assessment of Intratumoral Aromatase Activity
por: Hong, Yanyan, et al.
Publicado: (2009)

Predictors of premature discontinuation of outpatient treatment after discharge of patients with posttraumatic stress disorder
por: Wang, Hee Ryung, et al.
Publicado: (2015)

Incidence, predictors, and prognosis of premature discontinuation or switch of prasugrel or ticagrelor: the ATLANTIS - SWITCH study
por: Winter, Max-Paul, et al.
Publicado: (2019)

Joint Symptoms, Aromatase Inhibitor-Related Adverse Reactions, Are Indirectly Associated with Decreased Serum Estradiol
por: Honda, Junko, et al.
Publicado: (2011)

Risk Factors for Premature Aging in Childhood Cancer Survivors
por: Krawczuk-Rybak, Maryna, et al.
Publicado: (2019)

Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor–Associated Musculoskeletal Symptoms
por: Henry, N Lynn, et al.
Publicado: (2021)

The effect of exercise on aromatase inhibitor-induced musculoskeletal symptoms in breast cancer survivors :a systematic review and meta-analysis
por: Lu, Geling, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dfmb0q676qo28gnneh7nud7806